BNP Paribas Exane Issues Positive Forecast for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble (NYSE:PG) had its target price increased by equities research analysts at BNP Paribas Exane from $177.00 to $189.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. BNP Paribas Exane‘s price target would suggest a potential upside of 17.01% from the company’s previous close.

A number of other analysts have also recently weighed in on the company. Barclays raised their price target on Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. The Goldman Sachs Group reiterated a “neutral” rating and issued a $161.00 price objective on shares of Procter & Gamble in a report on Thursday. Royal Bank Of Canada set a $169.00 price objective on Procter & Gamble in a report on Friday. HSBC reissued a “hold” rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Finally, Citigroup boosted their target price on Procter & Gamble from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, October 9th. Fourteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $167.00.

Procter & Gamble Stock Down 2.5%

Shares of PG traded down $4.07 during midday trading on Friday, reaching $161.52. The stock had a trading volume of 5,132,319 shares, compared to its average volume of 9,740,908. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $167.25. The company’s fifty day simple moving average is $148.08 and its two-hundred day simple moving average is $146.99. The company has a market cap of $375.17 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 3.90 and a beta of 0.39. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.99 EPS. Equities research analysts expect that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Activity

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 359 shares of the company’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer owned 1,271 shares in the company, valued at $184,600.04. This represents a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the sale, the insider owned 187,001 shares in the company, valued at $26,888,873.79. This trade represents a 2.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 15,135 shares of company stock worth $2,189,970 over the last three months. Company insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Procter & Gamble in the 2nd quarter valued at $27,862,105,000. State Street Corp increased its stake in Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after purchasing an additional 965,461 shares during the period. Bank of America Corp DE acquired a new position in Procter & Gamble in the second quarter valued at $3,850,628,000. Bank of New York Mellon Corp purchased a new stake in shares of Procter & Gamble in the second quarter valued at about $2,281,505,000. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Procter & Gamble by 2.6% in the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock valued at $1,704,182,000 after buying an additional 300,280 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G reported fiscal Q1 adjusted earnings of $2.00 per share and revenue of $23.28 billion, exceeding consensus estimates of $1.89 and $22.80 billion, respectively. Revenue increased 4% year over year. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Organic sales growth reaccelerated 4%, with volume contributing 2.4 percentage points. Stronger demand in laundry, home-care and other categories, along with favorable product mix and productivity savings, helped drive the beat.
• Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition, while maintaining a roughly $86.0 billion-$87.7 billion revenue range and $6.89-$7.11 EPS guidance. P&G raises FY2027 sales outlook
• Positive Sentiment: JPMorgan raised its price target from $162 to $180 and upgraded its stance to overweight, indicating confidence that resilient volumes and improving operating leverage can support further appreciation.
• Neutral Sentiment: TD Cowen increased its target from $150 to $166 but retained a hold rating, signaling limited upside at the current valuation. P&G trades at approximately 24 times earnings, making sustained growth important for additional gains.
• Negative Sentiment: Higher commodity, energy, transportation and fuel costs are expected to pressure fiscal-year profit by roughly $1.4 billion. Analysts also noted that margins remain under strain despite pricing, productivity measures and favorable mix. P&G flags bigger profit hit from commodity costs
• Negative Sentiment: The company’s revenue guidance range remains below the roughly $88.8 billion analyst consensus, and investors still face uncertainty over whether volume growth can offset inflationary costs through the rest of fiscal 2027.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.